|
|
| Neurologie > Etude de marché sectorielle |
|
|
|
|
€ 3 091,00 |
Editeur
: |
Global Industry Analyst |
Langue
: |
Anglais |
Date de publication : |
Février 2006 |
Taille du document : |
408 |
Autres informations : |
Description , Table des matières |
| |
|
|
|
|
| |
Documents Publics |
1,200,000
documents |
Téléchargement illimités |
|
|
|
Etudes Privées |
50,000 rapports et études |
Paiement à la piéce |
|
|
|
|
| |
|
1.Télécharger nos rapports publics
Accés complet à plus de 1,2 Million de documents publics : études de marché, statistiques sectorielles, fiches pays, monographie d'entreprises, veille concurentielle, rapports annuels...
|
| Nos documents publics sur le même théme (2) |
|
|
|
| 12 pages | Septembre 1998 | Anglais
|
|
|
| Main
focus: |
therapeutic classes,pharmaceuticals,...,...
|
| Research
focus: |
demand analysis,market size and estimates, |
| Geographic
focus: |
usa,croatia,united kingdom,canada |
| |
|
|
|
|
| 0 pages | Octobre 2002 | Anglais
|
|
|
| Main
focus: |
antidepressant,antidepressants,insomnia,zoloft,...,...
|
| Research
focus: |
demand analysis,market size and estimates, |
| Geographic
focus: |
usa,france,united kingdom |
| |
|
|
|
|
| Autres recherches sur le même thème |
|
|
|
| |
| |
|
| |
|
2.
Rechercher d'autres rapports et études à commander
Rechercher et commander ici parmi 50.000 études de marché publiées par les principaux instituts d'études internationaux
|
| Rapports privés en relation |
|
Neuroprotection in Stroke - Protecting the Brain Sells
54 pages | Janvier 2005 |
IntroductionStroke is one of the leading causes of death and adult disability worldwide.
Nevertheless, acute treatments for stroke are severely limited.
Neuroprotective drugs, which boast the ab |
1 520,00 €
|
| |
| |
Pipeline Insight: Neuropathic Pain - Pipeline Drugs Fail to Nail Neuropathic Pain
183 pages | Juillet 2005 |
IntroductionThe neuropathic pain market has traditionally been a poorly defined area, with widely varying drug classes prescribed.
With many drugs now in clinical trials for key neuropathic pain su |
9 120,00 €
|
| |
| |
05-070: The Neuroscience Perspective: Opportunities for Market Entry & Expansion
138 pages | Octobre 2005 |
This report provides suppliers with critical information regarding neuroscientists’ preferred techniques and instrumentation in four strategic areas: nucleic acids, proteins, cells and imaging |
2 400,00 €
|
| |
| |
Stakeholder Insight: Major Depressive Disorder - Duloxetine - Fulfilling An Unmet Need?
224 pages | Mars 2006 |
IntroductionMajor Depressive Disorder (MDD) is estimated to affect over 34 million individuals yearly across the seven major markets.
Only a fraction of this patient population is treated adequatel |
12 160,00 €
|
| |
| |
MarketWatch: CNS
29 pages | Janvier 2006 |
Datamonitor's CNS MarketWatch is a one-stop news shop for timepressed executives.
It provides monthly insight into the key events in the CNS industry.
The report contains the latest news, analys |
170,00 €
|
| |
| |
MarketWatch: CNS
25 pages | Janvier 2005 |
Datamonitor's CNS MarketWatch is a one-stop news shop for timepressed executives.
It provides monthly insight into the key events in the CNS industry.
The report contains the latest news, analys |
160,00 €
|
| |
| |
Alcohol/Substance Abuse & Dependency - Clinical Guideline
89 pages | Octobre 2006 |
Alcohol/Substance Abuse & Dependency - Clinical Guideline |
47,00 €
|
| |
| |
Nutraceuticals - Targeting Consumers Aged 35+
154 pages | Septembre 2000 |
Not only does the 35+ consumer group account for a significant and growing percentage of the total population; it is also at the greatest risk of major illnesses.
Despite advances in medicine |
955,00 €
|
| |
| |
MarketWatch: CNS
27 pages | Mai 2005 |
Datamonitor's CNS MarketWatch is a one-stop news shop for timepressed executives.
It provides monthly insight into the key events in the CNS industry.
The report contains the latest news, analys |
160,00 €
|
| |
| |
Antidepressants
408 pages | Février 2006 |
This report analyzes the worldwide markets for Antidepressants in Millions of US$.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific (excluding Ja |
3 091,00 €
|
| |
| |
|
| |
| Autres secteurs en relation |
|
|
|
| |
|
| |
| |
| Présentation de l'étude de marché - Description & Table des matières |
|
|
|
This report analyzes the worldwide markets for Antidepressants in Millions of US$. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Latin America. Annual forecasts are provided for each region for the period of 2000 through 2010. The report profiles 45 companies including many key and niche players worldwide such as AstraZeneca PLC, Bristol-Myers Squibb, Eli Lilly and Co., Forest Laboratories, GlaxoSmithKline PLC, H. Lundbeck A/S, Merck & Co., Novartis AG, Organon International, Inc., Pfizer, Inc., Solvay SA, and Wyeth Pharmaceuticals.
|
|
|
PPLSEN
|
|
|
|
|
